Partnership to Develop Companion Diagnostic Kit for Lymphoma
Foresight Diagnostics and QIAGEN have entered a global partnership to develop and commercialize a companion diagnostic kit for lymphoma.
Category: Lymphoma
Lymphoma
Latest
Lymphoma
Latest
What’s Next for Liquid Biopsy Tests?
Foresight Diagnostics CEO and CSO Jake Chabon gives an overview of what’s next for liquid biopsy testing, and how it will impact the continuum of care.
Lymphoma
Latest
Sysmex Launches Sample Preparation System for Flow Cytometry
The automated PS-10 sample preparation system streamlines workflows and standardizes clinical flow cytometry testing.
Nano-Signature Discovery Could Revolutionize Cancer Diagnosis
The new technology has proved to be up to 90% accurate in tests involving 200 human cancer samples and normal DNA.
Read More
Determining Molecular Response in Chronic Myeloid Leukemia
Droplet digital PCR can provide a more accurate assessment of low levels of BCR-ABL mRNA than quantitative real-time PCR.
Read More
ASCP, ASH, and CAP Invite Public Comment on Lymphoma Guideline
Multidisciplinary guidance document focuses on specimen requirements for the diagnosis of lymphoma.
Read More
August/September 2017 Product Spotlight: New Products Showcase
This month’s Product Spotlight features new products from such companies as Advanced Instruments, Beckman Coulter, and Thermo Fisher Scientific.
Read More
HTG Molecular Diagnostics Launches NGS-Based Cell-of-Origin Assay for Diffuse Large B-Cell Lymphomas
HTG’s next-generation sequencing assay enables subtyping of DLBCL as activated B-cell-like or germinal center B-cell-like.
Read More
NCI Awards $1.4 Million Grant to Advanced Cell Diagnostics
Under a new grant from the National Cancer Institute, Advanced Cell Diagnostics will partner with the Cleveland Clinic to develop an ultrasensitive diagnostic test for B-cell lymphoma.
Read MorePathGroup Collaboration to Offer Genomic Profiling of Hematologic Malignancies
A new collaboration plans to provide genomic profiling and information for patients that have been unsuccessful on repeated therapy for the group of cancers that include leukemias, lymphomas, and myeloproliferative and myelodysplastic diseases.
Read MoreTool Could Help Assessment of Hodgkin’s Lymphoma and Breast Cancer
A new study shows the MultiOmyx profile could improve disease assessment for both diseases using multiplex proteins.
Read More
Sequenta Expands Sample Types Accepted for ClonoSIGHT MRD Test for Leukemia, Lymphoma
Ultra-sensitive detection of minimal residual disease now available to more people with blood cancers.
Read More
Diagnovus Debuts Gene Expression Assay for Patients With Diffuse Large B-Cell Lymphoma
Assay can aid physicians in better risk stratification and treatment of patients with diffuse large B-cell lymphoma.
Read More
Sequenta Introduces ClonoSIGHT, Sequencing-Based MRD Test for Leukemia, Lymphoma
The test has been shown to offer sensitivity for the detection of residual cancer cells in marrow or blood.
Read MoreTesting for Lymphoma and Leukemia
With so many types of lymphoma, there’s a wide range of corresponding lab tests to detect their presence in patients. Here, CLP takes a look at testing for the most common type of lymphoma (diffuse large B-cell
Read More